BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20649944)

  • 41. Classical and emerging roles of vitamin D in hepatitis C virus infection.
    Gutierrez JA; Parikh N; Branch AD
    Semin Liver Dis; 2011 Nov; 31(4):387-98. PubMed ID: 22189978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D deficiency and HCV chronic infection: what comes first?
    Bitetto D; Fabris C; Falleti E; Toniutto P
    J Hepatol; 2011 Oct; 55(4):944-5; author reply 945. PubMed ID: 21349298
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of hepatitis C virus by vitamin D.
    Murayama A; Kato T
    Vitam Horm; 2021; 117():227-238. PubMed ID: 34420582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation.
    Kubeczko M; Nowara E; Karwasiecka D; Siewior G; Czajka-Francuz P; Chudek J; Wojnar J
    Hematology; 2016 Jul; 21(6):343-50. PubMed ID: 26902783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response.
    Backstedt D; Pedersen M; Choi M; Seetharam A
    Ann Gastroenterol; 2017; 30(3):344-348. PubMed ID: 28469365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection.
    Cacopardo B; Camma C; Petta S; Pinzone MR; Cappellani A; Zanghi A; Nicolosi A; Nunnari G
    Front Biosci (Elite Ed); 2012 Jan; 4(4):1276-86. PubMed ID: 22201953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis.
    Corey KE; Zheng H; Mendez-Navarro J; Delgado-Borrego A; Dienstag JL; Chung RT;
    PLoS One; 2012; 7(2):e27144. PubMed ID: 22359532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D-binding protein gene polymorphisms may contribute to the racial disparity in genotype 1 chronic hepatitis C treatment outcome.
    Weintraub SJ; Fleckenstein JF; Marion TN; Madey MA
    Hepatology; 2013 Nov; 58(5):1864. PubMed ID: 23553666
    [No Abstract]   [Full Text] [Related]  

  • 49. Reply: To PMID 22610885.
    Falleti E; Fabris C; Toniutto P
    Hepatology; 2013 Nov; 58(5):1864-5. PubMed ID: 23553733
    [No Abstract]   [Full Text] [Related]  

  • 50. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection.
    Chen HW; Chiu YL; Hsieh TY; Chen PJ; Huang TY; Lin HH; Shih YL; Lin JC
    J Inflamm Res; 2020; 13():1207-1218. PubMed ID: 33402842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D supplementation for autoimmune hepatitis: A need for further investigation.
    Sergi CM
    World J Hepatol; 2022 Jan; 14(1):295-299. PubMed ID: 35126856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C?
    Puri P
    J Clin Exp Hepatol; 2012 Dec; 2(4):396-8. PubMed ID: 25755461
    [No Abstract]   [Full Text] [Related]  

  • 53. Could vitamin d supplementation benefit patients with chronic liver disease?
    Barchetta I
    Gastroenterol Hepatol (N Y); 2012 Nov; 8(11):755-7. PubMed ID: 24672412
    [No Abstract]   [Full Text] [Related]  

  • 54. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
    Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
    Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
    Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
    J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between vitamin D and hepatitis C virus infection: a meta-analysis.
    Villar LM; Del Campo JA; Ranchal I; Lampe E; Romero-Gomez M
    World J Gastroenterol; 2013 Sep; 19(35):5917-24. PubMed ID: 24124339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D for your patients with chronic hepatitis C?
    Rahman AH; Branch AD
    J Hepatol; 2013 Jan; 58(1):184-9. PubMed ID: 22871501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.
    Martineau AR; Jolliffe DA; Greenberg L; Aloia JF; Bergman P; Dubnov-Raz G; Esposito S; Ganmaa D; Ginde AA; Goodall EC; Grant CC; Janssens W; Jensen ME; Kerley CP; Laaksi I; Manaseki-Holland S; Mauger D; Murdoch DR; Neale R; Rees JR; Simpson S; Stelmach I; Trilok Kumar G; Urashima M; Camargo CA; Griffiths CJ; Hooper RL
    Health Technol Assess; 2019 Jan; 23(2):1-44. PubMed ID: 30675873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.
    Yokoyama S; Takahashi S; Kawakami Y; Hayes CN; Kohno H; Kohno H; Tsuji K; Aisaka Y; Kira S; Yamashina K; Nonaka M; Moriya T; Kitamoto M; Aimitsu S; Nakanishi T; Kawakami H; Chayama K
    J Viral Hepat; 2014 May; 21(5):348-56. PubMed ID: 24716637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E.
    Moatasim Y; Kutkat O; Osman AM; Gomaa MR; Okda F; El Sayes M; Kamel MN; Gaballah M; Mostafa A; El-Shesheny R; Kayali G; Ali MA; Kandeil A
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.